Are phospholipid-binding proteins in vivo phospholipase inhibitors?
- PMID: 2494377
- DOI: 10.1007/BF01711345
Are phospholipid-binding proteins in vivo phospholipase inhibitors?
Abstract
Apo C1, a 6.5 kD protein component of VLDL, inhibits the hydrolysis of DPPC vesicles by pancreatic PLA2 and the hydrolysis of cellular phospholipids by endogenous phospholipases by interaction with the substrate. It is suggested that apo C1 and similar phospholipid-binding proteins modulate in vivo phospholipase activity, because they do so in cell homogenates with concentrations approximately equal to those found in the plasma.
Similar articles
-
Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes.Biochim Biophys Acta. 1990 Feb 6;1042(2):188-92. doi: 10.1016/0005-2760(90)90006-j. Biochim Biophys Acta. 1990. PMID: 2302419
-
Inhibition of phospholipases by Met-Leu-Phe-Ile-Leu-Ile-Lys-Arg-Ser-Arg-His-Phe, C terminus of middle-sized tumor antigen.Arch Biochem Biophys. 1985 Jan;236(1):195-204. doi: 10.1016/0003-9861(85)90619-8. Arch Biochem Biophys. 1985. PMID: 2857079
-
Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.Pharmacol Res Commun. 1984 Jul;16(7):637-45. doi: 10.1016/s0031-6989(84)80042-9. Pharmacol Res Commun. 1984. PMID: 6433363
-
Modification of the arachidonic acid cascade through phospholipase A2 dependent mechanisms.Adv Prostaglandin Thromboxane Leukot Res. 1990;20:217-23. Adv Prostaglandin Thromboxane Leukot Res. 1990. PMID: 2144695 Review. No abstract available.
-
Phospholipases in biology and medicine.Clin Biochem. 1990 Oct;23(5):349-70. doi: 10.1016/0009-9120(90)90051-u. Clin Biochem. 1990. PMID: 2253331 Review.